1. Liu, Haoyu, Liu, Dawei, Li, Zhipeng. . Expression and clinical significance of ENC1 in gastrointestinal tumors: Bioinformatics analysis based on a public gene database. In Journal of gastrointestinal oncology, 14, 824-832. doi:10.21037/jgo-23-217. https://pubmed.ncbi.nlm.nih.gov/37201052/
2. Li, Lin, Wang, Nan, Zhu, Mingzhi, Wang, Xinxing, Gu, Yuanyan. 2021. Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma. In Cell death & disease, 12, 777. doi:10.1038/s41419-021-04060-5. https://pubmed.ncbi.nlm.nih.gov/34362881/
3. Feng, Jie, Hong, Lichuan, Wu, Yonggang, Zhuang, Zhengping, Zhang, Yazhuo. 2014. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas. In Journal of neuro-oncology, 119, 307-15. doi:10.1007/s11060-014-1479-1. https://pubmed.ncbi.nlm.nih.gov/24916845/
4. He, Lingling, He, Wenjing, Luo, Ji, Xu, Minjuan. 2022. Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer. In Frontiers in cell and developmental biology, 10, 919637. doi:10.3389/fcell.2022.919637. https://pubmed.ncbi.nlm.nih.gov/36531950/
5. Fan, Shaohua, Wang, Yanyan, Sheng, Ning, Hu, Bin, Zheng, Yuanlin. 2018. Low expression of ENC1 predicts a favorable prognosis in patients with ovarian cancer. In Journal of cellular biochemistry, 120, 861-871. doi:10.1002/jcb.27447. https://pubmed.ncbi.nlm.nih.gov/30125994/
智鼠故事 
